Local renin-angiotensin system is involved in K+-induced aldosterone secretion from human adrenocortical NCI-H295 cells

Hypertension

Volumn 33, Issue 4, 1999, Pages 1025-1030

  Hilbers, Urte ^c   Peters, Jörg ^c   Bornstein, Stefan R ^b   Correa, Fernando M A ^a   Jöhren, Olaf ^a   Saavedra, Juan M ^a   Ehrhart Bornstein, Monika ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c Bldg 10 ^*

Author keywords

Aldosterone; Angiotensin II; NCI H295 cell line; Potassium; Renin angiotensin system

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSINOGEN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; LOSARTAN; POTASSIUM; RENIN;

ADRENAL CORTEX CARCINOMA; ALDOSTERONE RELEASE; ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BINDING; HORMONE DETERMINATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RNA ANALYSIS;

EID: 0032920615     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.4.1025     Document Type: Article

References (35)

1. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev. 1977;57:313-370.
2. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP. Intraadrenal interactions in the regulation of adrenocortical steroido-genesis. Endocr Rev. 1998;19:101-143.
3. Peters J, Ganten D. Adrenal renin expression and its role in ren-2 transgenic rats TGR(mREN2)27. Horm Metab Res. 1998;30:350-354.
4. Vinson GP, Ho MM. The adrenal renin/angiotensin system in the rat. Horm Metab Res. 1998;30:355-359.
5. Mulrow PJ. Renin-angiotensin system in the adrenal. Horm Metab Res. 1998;30:346-349.
6. Mercure C, Jutras I, Day R, Seidah NG, Reudelhuber TL. Prohormone convertase PCS is a candidate processing enzyme for prorenin in the human adrenal cortex. Hypertension. 1996;28:840-846.
7. Ganong WF. Origin of the angiotensin II secreted by cells. Proc Soc Exp Biol Med. 1994;205:213-219.
8. Gazdar AF, Oie HK, Shackleton CH, Chen TR, Triche TJ, Myers CE. Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res. 1990;50:5488-5496.
9. Bird IM, Mason JI, Rainey WE. Hormonal regulation of angiotensin II type 1 receptor expression and AT1-R mRNA levels in human adrenocortical cells. Endocr Res. 1995;21:169-182.
10. Bird IM, Hanley NA, Word RA, Mathis JM, McCarthy JL, Mason JI. Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. Endocrinology. 1993;133: 1555-1561.
11. 2+-regulated expression of steroid hydroxylases in H295R human adrenocortical cells. Endocrinology. 1995;136:5677-5684.
12. Glasow A, Breidert M, Haidan A, Anderegg U, Kelly PA. Bornstein SR. Functional aspects of the effect of prolactin (PRL) on adrenal steroido-genesis and distribution of the PRL receptor in the human adrenal gland. J Clin Endocrinol Metab. 1996;81:3103-3111.
13. Peters J, Hilgers KF, Masergluth C, Kreutz R. Role of the circulating renin-angiotensin system in the pathogenesis of hypertension in transgenic rats, TGR (mREN2) 27. Clin Exp Hypenens 1996;18: 933-948.
14. Jöhren O, Imboden H, Hauser W, Maye I, Sanvitto GL, Saavedra JM. Localization of angiotensin-converting enzyme, angiotensin II. angiotensin II receptor subtypes, and vasopressin in the mouse hypothalamus. Brain Res. 1997;757:218-227.
15. Nazarali AJ, Gutkind JS, Saavedra JM. Calibration of 1251-polymer standards with 1251-brain paste standards for use in quantitative receptor autoradiography. J Neurosci Methods. 1989;30:247-253.
16. Haidan A, Bornstein SR, Glasow A, Uhlmann K, Lübke C, Ehrhart-Bornstein M. Basal steroidogenic activity of adrenocortical cells is increased 10-fold by coculture with chromaffin cells. Endocrinology. 1998;139:772-780.
17. Racz K, Pinet F, Gasc JM, Guyene TT, Corvol P. Coexpression of renin, angiotensinogen, and their messenger ribonucleic acids in adrenal tissues. J Clin Endocrinol Metab. 1992;75:730-737.
18. Gonzalez-Garcia C, Keiser HR. Angiotensin II and angiotensin converting enzyme binding in human adrenal gland and pheochromocytomas. J Hypenens. 1990;8:433-441.
19. Dzau VJ, Sasamura H, Hein L. Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications. J Hypertens Suppl. 1993;11:S13-S18.
20. Saye JA, Ragsdale NV, Carey RM, Peach MJ. Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes. Am J Physiol. 1993; 264:C1570-C1576.
21. Urata H, Nishimura H, Ganten D. Mechanisms of angiotensin II formation in humans. Eur Heart J. 1995;16(suppl N):79-85.
22. Urata H, Nishimura H, Ganten D, Arakawa K. Angiotensin-converting enzyme-independent pathways of angiotensin II formation in human tissues and cardiovascular diseases. Blood Press Suppl. 1996;2:22-28.
23. Strittmatter SM, Thiele EA, Kapiloff MS, Snyder SH. A rat brain isozyme of angiotensin-converting enzyme: unique specificity for amidated peptide substrates. J Biol Chem. 1985;260:9825-9832.
24. Genden EM, Molineaux CJ. Inhibition of endopeptidase-24.15 decreases blood pressure in normotensive rats. Hypertension. 1991;18:360-365.
25. Hooper NM, Hryszko J, Oppong SY, Turner AJ. Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P. Hypertension. 1992; 19:281-285.
26. Chiou CY, Kifor I, Moore TJ, Williams GH. The effect of losartan on potassium-stimulated aldosterone secretion in vitro. Endocrinology. 1994;134:2371-2375.
27. Naville D, Lebrethon MC, Kermabon AY, Rouer E, Benarous R, Saez JM. Characterization and regulation of the angiotensin II type-1 receptor (binding and mRNA) in human adrenal fasciculata-reticularis cells. FEBS Lett. 1993;321:184-188.
28. Quinn SJ, Williams CH. Regulation of aldosterone secretion. In: James VHT, ed. The Adrenal Gland. New York, NY: Raven Press; 1992: 159-189.
29. Shier DN, Kusano E, Stoner GD, Franco-Saenz R, Mulrow PJ. Production of renin, angiotensin II, and aldosterone by adrenal explant cultures: response to potassium and converting enzyme inhibition. Endocrinology. 1989;125:486-491.
30. Yamaguchi T, Naito Z, Stoner GD, Franco-Saenz R, Mulrow PJ. Role of the adrenal renin-angiotensin system on adrenocorticotropic hormone- and potassium-stimulated aldosterone production by rat adrenal glomerulosa cells in monolayer culture. Hypertension. 1990;16:635-641.
31. Gupta P, Franco-Saenz R, Mulrow PJ. Locally generated angiotensin-II in the adrenal-gland regulates basal, corticotropin-stimulated, and potassium-stimulated aldosterone secretion. Hypertension. 1995;25: 443-448.
32. Kifor I, Moore TJ, Fallo F, Sperling E, Chiou CY, Menachery A. Potassium-stimulated angiotensin release from superfused adrenal capsules and enzymatically dispersed cells of the zona glomerulosa. Endocrinology. 1991;129:823-831.
33. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344:541-544.
34. Sander M, Ganten D, Mellon SH. Role of adrenal renin in the regulation of adrenal steroidogenesis by corticotropin. Proc Natl Acad Sci U S A. 1994;91:148-152.
35. Yamaguchi T, Tokita Y, Franco-Saenz R, Mulrow PJ, Peters J, Ganten D. Zonal distribution and regulation of adrenal renin in a transgenic model of hypertension in the rat. Endocrinology. 1992;131:1955-1962.